Method for producing steviol and steviol glycoside using AOBGL1 homolog

US11268118B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11268118-B2
Application numberUS-201615771191-A
CountryUS
Kind codeB2
Filing dateOct 28, 2016
Priority dateOct 30, 2015
Publication dateMar 8, 2022
Grant dateMar 8, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a method for producing a steviol glycoside and/or steviol, said method including a step in which a steviol glycoside having at least one unbranched β1,2-glycosidic bond is reacted with the glycosidase AOBGL1 and/or AOBGL3, or a variant thereof, so as to cleave the β1,2-glycosidic bond.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for producing a steviol glycoside having no unbranched β-1,2-glucoside bond, the method comprising: reacting a protein selected from the group consisting of proteins (a) to (c) shown below with a steviol glycoside having at least one unbranched β-1,2-glucoside bond, thereby cleaving said unbranched β-1,2-glucoside bond: (a) a protein comprising the amino acid sequence of SEQ ID NO: 3 or 4; (b) a protein comprising an amino acid sequence wherein 1 to 77 amino acids have been deleted, substituted, inserted, and/or added in the amino acid sequence of SEQ ID NO: 3 or 4, and having an activity to cleave an unbranched β-1,2-glucoside bond of a steviol glycoside; and (c) a protein having an amino acid sequence having 90% or more sequence identity to the amino acid sequence of SEQ ID NO: 3 or 4, and having an activity to cleave an unbranched β-1,2-glucoside bond of a steviol glycoside. 2. The method of claim 1 , wherein the protein selected from the group consisting of the proteins (a) to (c) further comprises a secretory signal peptide. 3. The method of claim 2 , wherein the secretory signal peptide is a peptide consisting of the amino acid sequence set forth in any one of SEQ ID NOS: 28, 30, 32, 34, and 36. 4. The method of claim 3 , wherein the steviol glycoside having at least one unbranched β-1,2-glucoside bond is selected from rebaudioside D, rebaudioside E, stevioside, and steviolbioside. 5. The method of claim 4 , wherein the steviol glycoside having no unbranched β-1,2-glucoside bond is selected from rubusoside, rebaudioside A, and steviolmonoside. 6. A method for producing at least one of rebaudioside B and steviol comprising reacting together: a protein selected from the group consisting of proteins (a) to (c) shown below, a protein selected from the group consisting of proteins (d) to (f) shown below, and a steviol glycoside having at least one unbranched β-1,2-glucoside bond: (a) a protein comprising the amino acid sequence of SEQ ID NO: 3 or 4; (b) a protein comprising an amino acid sequence wherein 1 to 77 amino acids have been deleted, substituted, inserted, and/or added in the amino acid sequence of SEQ ID NO: 3 or 4, and having an activity to cleave an unbranched β-1,2-glucoside bond of a steviol glycoside; (c) a protein having an amino acid sequence having 90% or more sequence identity to the amino acid sequence of SEQ ID NO: 3 or 4, and having an activity to cleave an unbranched β-1,2-glucoside bond of a steviol glycoside; (d) a protein comprising the amino acid sequence of SEQ ID NO: 7 or 8; (e) a protein comprising an amino acid sequence wherein 1 to 77 amino acids have been deleted, substituted, inserted, and/or added in the amino acid sequence of SEQ ID NO: 7 or 8, and having an activity to cleave a monoglucoside bond and/or monoglucosyl ester bond of a steviol glycoside; and (f) a protein having an amino acid sequence having 90% or more sequence identity to the amino acid sequence of SEQ ID NO: 7 or 8, and having an activity to cleave a monoglucoside bond and/or monoglucosyl ester bond of a steviol glycoside. 7. The method of claim 6 , wherein the steviol glycoside having at least one unbranched β-1,2-glucoside bond comprises one or more steviol glycosides selected from rebaudioside D, rebaudioside E, stevioside, and steviolbioside.

Assignees

Inventors

Classifications

  • C12N9/2434Primary

    acting on beta-1,4-glucosidic bonds · CPC title

  • Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora · CPC title

  • Fungi (culture of mushrooms A01G18/00; as new plants A01H15/00); Culture media therefor · CPC title

  • targeting to the medium outside of the cell, e.g. type III secretion · CPC title

  • Bacteria; Culture media therefor · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11268118B2 cover?
The present invention provides a method for producing a steviol glycoside and/or steviol, said method including a step in which a steviol glycoside having at least one unbranched β1,2-glycosidic bond is reacted with the glycosidase AOBGL1 and/or AOBGL3, or a variant thereof, so as to cleave the β1,2-glycosidic bond.
Who is the assignee on this patent?
Suntory Holdings Ltd
What technology area does this patent fall under?
Primary CPC classification C12N9/2434. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).